In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability

Expert Opinion on Drug Metabolism and Toxicology

Volumn 4, Issue 1, 2008, Pages 65-76

  Fatouros, Dimitrios G ^a   Mullertz, Anette ^b  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

In vitro digestion model; In vitro in vivo correlations; Physicochemical characterisation of lipolytic products; Self emulsifying drug delivery systems

Indexed keywords

CINNARIZINE; COLECALCIFEROL; CYCLOSPORIN; CYCLOSPORIN A; DANAZOL; DEXAMETHASONE; DIACYLGLYCEROL; DIAZEPAM; FLUPENTIXOL; GRISEOFULVIN; HALOFANTRINE; LIPID; MONOACYLGLYCEROL; PROBUCOL; PROGESTERONE; RITONAVIR; SAQUINAVIR; TRIACYLGLYCEROL;

AQUEOUS SOLUTION; BIOPHYSICS; COLLOID; CORRELATION ANALYSIS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; ENZYME DEGRADATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLUID; LIPID DEGRADATION; LIPID SOLUBILITY; LIPOLYSIS; LIPOPHILICITY; NONHUMAN; REVIEW; SIMULATION; STOMACH JUICE;

ANIMALS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; LIPIDS; LIPOLYSIS; PHARMACEUTICAL PREPARATIONS;

EID: 39049129258     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425255.4.1.65     Document Type: Review

References (86)

1. Porter CJ, Charman WN. Uptake of drugs into the intestinal lymphatic after oral administration. Adv Drug Deliv Rev 1997;25:71-89
2. Charman WN, Stella VJ. Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules. Int J Pharm 1986;34(1-2):175-8
3. Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci 2000;11 (Suppl 2):S93-8
4. Khossravi M, Kao YH, Mrsny RJ, et al. Analysis methods of polysorbate 20: a new method to assess the stability of polysorbate 20 and established methods that may overlook degraded polysorbate 20. Pharm Res 2002;5(19):634-9
5. Seeballuck F, Ashford MB, O'Driscoll. The effects of pluronics block copolymers and cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells. Pharm Res 2003;20(7): 1085-92
6. Porter CJ, Charman WN. Uptake of drugs into the intestinal lymphatic after oral administration. Adv Drug Deliv Rev 1997;25:71-89
7. Fernandez S, Jannin V, Rodier JD, et al. Comparative study on digestive lipase activities on the self emulsifying excipient labrasol, medium chain glycerides and PEG esters. Biochim Biophys Acta 2007;1771(5):633-40
8. Larsen A, Ritter N, Bibuljica A, et al. Lipolysis of macrogolglycerides and effects on solubility and solubilisation of danazol; a poorly soluble model drug compound. (Submitted for publication)
9. Rigler MW, Honkanen RE, Patton JS. Visualisation by freeze fracture, in vitro and in vivo, of the products of fat digestion. J Lipid Res 1986;27(8):836-57
10. Hernell O, Staggers JE, Carey MC. Physicochemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase behavior and aggregation states of luminal lipids during duodenal fat digestion in health adult human beings. Biochemistry 1990;29(8):2041-56
11. Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev 2007;59(7):667-76
12. Hunt JN, Knox MT. A relation between the chain length of fatty acids and the slowing of gastric emptying. J Physiol 1968;194(2):327-36
13. Ladas SD, Isaacs PE, Murphy GM, et al. Comparison of the effects of medium and long chain triglyceride containing liquid meals on gall bladder and small intestinal function in normal man. Gut 1984;25(4):405-11
14. Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Del Rev 1997;25:47-58
15. Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev 2007; in press
16. Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm 2000;50(1):179-88
17. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004;58(3):173-82
18. Gao P, Rush BD, Pfund WP, et al. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci 2003;92(12):2386-98
19. Gao P. Morozowich W. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv 2006;3(1):97-110
20. Garti N, Amar I, Yaghmur A, et al. Interfacial modification and structural transitions induced by guest molecules solubilized in U-type nonionic food-grade microemulsions. J Disper Sci Technol 2003;24(3-4):397-410
21. Garti N, Yaghmur A, Aserin A, et al. Solubilization of active-molecules in microemulsions for improved solubilization, and environmental protection. Coll Surf A Physicochem Eng Asp 2004;230(1-3):183-90
22. Spernath A, Aserin A. Microemulsions as carriers for drugs and nutraceuticals. Adv Colloid Interface Sci 2006;21:128-30:47-64
23. Shively ML, Thompson DC. Oral bioavailability of vancomycin solid-state emulsions. Int J Pharm 1995;117(1):119-22
24. Christensen KL, Pedersen GP, Kristensen HG. Physical stability of redispersible dry emulsions containing amorphous sucrose. Eur J Pharm Biopharm 2002;53(2):147-53
25. Nazzal S, Khan MA. Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters. Int J Pharm 2006;315(1-2):110-21
26. Dollo G, Le Corre P, Guerin A, et al. Spray-dried redispersible oil-in-water emulsion to improve oral bioavailability of poorly soluble drugs. Eur J Pharm Sci 2003;19(4):273-80
27. Mehnert S, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001;47(2-3):165-96
28. Porter CJ, Trevaskis N, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007;6(3):321-48
29. Zangeberg NH, Mullertz A, Kristensen HG, et al. A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. Eur J Pharm Sci 2001;14(2):115-22
30. Zangeberg NH, Mullertz A, Kristensen HG, et al. A dynamic in vitro lipolysis model. II. Evaluation of the model. Eur J Pharm Sci 2001;14(3):237-44
31. Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 2006;29(3-4):278-87
32. Gargouri Y, Moreau H, Verger. Gastric lipases: biochemical and physiological studies. Biochim Biophys Acta 1989v1006(3):255-71
33. Dressman JB, Berardi RR, Dermentzoglou LC, et al. Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm Res 1990;7(7):756-61
34. Carriere F, Barrowman JA, Verger R, et al. Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 1993;105(3):876-88
35. Armand M, Borel P, Pasquier B, et al. Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. Am J Physiol 1996;271:G172-83
36. Tangerman A, Van Schaik A, Van Der Hoek EW. Analysis of conjugated and unconjugated bile acids in serum and jejunal fluid of normal subjects. Clin Chim Acta 1986;159(2):123-32
37. Galia E, Nicolaides E, Horter D, et al. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res 1998;15(5):698-705
38. Pedersen BL, Mullertz A, Bronsted H, et al. A comparison of the solubility of danazol in human and simulated gastrointestinal fluids. Pharm Res 2000;(17)7:891-4
39. Persson EM, Gustafsson AS, Carlsson AS, et al. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids. Pharm Res 2005;12(22):2141-51
40. Ladas SD, Isaacs PE, Murphy GM, et al. Comparison of the effects of medium and long chain triglyceride containing liquid meals on gall bladder and small intestinal function in normal man. Gut 1984;25(4):405-11
41. Alvarez FJ, Stella VJ. The role of calcium ions and bile salts on the pancreatic lipase-catalyzed hydrolysis of triglyceride emulsions stabilized with lecithin. Pharm Res 1989;6(7):449-57
42. The United States Pharmacopeia/The National Formulary (USP24/NF19) 2000. United states Pharmacopeia Convection, Inc., Rockville, MD, USA; 1254-5
43. Carey MC, Small MC, Bliss CM. Lipid digestion and absorption. Ann Rev Physiol 1983;45:651-77
44. Reymond JP, Sucker H. In vitro model for cyclosporin intestinal absorption in lipid vehicles. Pharm Res 1988;5(10):673-76
45. Christensen JO, Schultz K, Mollgaard B, et al. Solubilization of poorly water-soluble drugs during in vitro lipolysis of medium and long chain triaglycerols. Eur J Pharm Sci 2004;23(3):87-96
46. Kaukonen AM, Boyd BJ, Porter CJ, et al. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharm Res 2004;21(2):245-53
47. Fatouros DG, Mullertz A. Using in vitro dynamic lipolysis modelling as a tool for exploring IVIVC relationships for oral lipid-based formulations. In: Lipid-Based Formulations for Oral Drug Delivery. Hauss D, editor, Taylor Francis Series: Drugs and the Pharmaceutical Sciences; 2007. p. 257-73
48. Reymond JP, Sucker H, Vonderscher J. In vivo model for cyclosporin intestinal absorption in lipid vehicles. Pharm Res 1988;5(10):677-9
49. Porter CJ, Kaukonen AM, Taillardat-Bertscinger A, et al. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. J Pharm Sci 2004;93(5):1110-21
50. Porter CJ, Kaukonen AM, Boyd BJ, et al. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm Res 2004;21(8):1405-12
51. Dahan A, Hoffman A. Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats. Pharm Res 2006;23(9):2165-74
52. Dahan A, Hoffman A. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. Eur J Pharm Biopharm 2007;67(1):96-105
53. Lind ML, Jacobsen J, Holm R, et al. Development of simulated intestinal fluids containing nutrients as transport media in the Caco-2 cell culture model: assessment of cell viability, monolayer integrity and transport of a poorly aqueous soluble drug and a substrate of efflux mechanisms. Eur J Pharm Sci 2007;32(4-5):261-70
54. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2000;45(1):89-121
55. 2O/n-decane inverse microemulsions. Langmuir 1995;11(5):1559-70
56. Constantinides PP, Scalart JP. Formulation and physical characterization of water-in-oil microemulsions containing long versus medium chain length glycerides. Int J Pharm 1997;158(1):57-68
57. Regev O, Ezrahi S, Aserin A, et al. A study of the microstructure of a four-component nonionic microemulsion by cryo-TEM, NMR, SAXS and SANS. Langmuir 1996;12(3):668-74
58. Vinson PK, Sheehan JG, Miller WG, et al. Viewing microemulsions with freeze-fracture transmission electron microscopy. J Phys Chem 1991;95(6):2546-50
59. Acosta E, Kurlat DH, Bisceglia M, et al. Induced electric birefringence and viscosity studies in microemulsions. Coll Surfaces A Physicochem Eng Aspects 1996;106(1):11-21
60. Hofmann AF, Borgstrom B. Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed Proc 1962;21:43-50
61. Hofmann AF, Borgstrom B. Intraluminal phase of fat digestion in man-lipid content of micellar + oil phases of intestinal content obtained during fat digestion + absorption. J Clin Invest 1964;43(2):247-57
62. Patton JS, Carey MC. Watching fat digestion. Science 1979;204(4389):145-8
63. Patton JS, Vetter RD, Hammosh M, et al. The light-microscopy of triglyceride digestion. Food Microstruc 19854(1):29-41
64. Small DM. A classification of biologic lipids based upon their interaction in aqueous systems. J Am Oil Chem Soc 1968;45:108-19
65. Lindstrom M, Ljusberg-Wahren H, Larsson K, et al. Aqueous lipid phases of relevance to intestinal fat digestion and absorption. Lipids 1981;16(10):749-54
66. Cistola DP, Atkinson D, Hamilton JA, et al. Phase behavior and bilayer properties of fatty acids: hydrated 1:1 acid soaps. Biochemistry 1986;25(10):2804-12
67. 2H NMR. J Lipid Res 1995;36(12):2478-92
68. Staggers JE, Hernell O, Staggers JE, et al. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. Biochemistry 1990;29(8):2028-40
69. Svard M, Schurtenberger P, Fontell K, et al. Micelles, vesicles and liquid crystals in the monoolein-sodium taurocholeate-water system. Phase behavior, NMR, self-diffusion and quasi-elastic light scattering. J Phys Chem 1988;92(8):2261-70
70. Ljusbergwahren H, Larsson K. A Raman spectroscopy study of mixed bile salt-monoglycerides micelles. Chem Phys Lipids 1981;28(1):25-32
71. Kossena GA, Boyd BJ, Porter CJH, et al. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. J Pharm Sci 2003;92(3):634-48
72. Kossena GA, Charman WN, Boyd BJ, et al. Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug. J Pharm Sci 2005;94(3):481-92
73. Fatouros DG, Bergenstahl B, Mullertz A. Morphological observations on a lipid-based drug delivery system during in vitro digestion. Eur J Pharm Sci 2007;31(2):85-94
74. Fatouros DG, Deen GR, Arleth L, et al. Structural development of Self Nano Emulsifying Drug Delivery Systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering. Pharm Res 2007;24(10):1844-53
75. Vinson P, Talmon Y, Walter A. Vesicle-micelle transition of phosphatidylcholine and octyl glucoside elucidated by cryo-transmission electron microscopy. Biophys J 1989;56(4):669-81
76. Walter A, Vinson PK, Kaplun A, et al. Intermediate structures in the cholate-phosphatidylcholine vesicle-micelle transition. Biophys J 1991;60(6):1315-25
77. Bellare JR, Davis HT, Scriven LE, et al. Controlled environment vitrification system. An improved sample preparation technique. J Elec Micr Tech 1988;10(1):87-111
78. Dubochet J, Adrian M, Chang J, et al. Cryo-electron microscopy of vitrified specimens. Q Rev Biophys 1988;21(2):129-228
79. Caffrey M. The study of lipid phase transition kinetics by time-resolved X-ray diffraction. Ann Rev Biophys Biophys Chem 1989;18:159-86
80. Rigler MW, Patton JS. The production of liquid crystalline product phase by pancreatic lipase in the absence of bile salts. Biochim Biophys Acta 1983;751(3):444-54
81. Rube A, Klein S, Mader K. Monitoring of in vitro fat digestion by electron paramagnetic resonance spectroscopy. Pharm Res 2006;23(9):2024-9
82. Nielsen FS, Gibault E, Ljusberg-Wahren H, et al. Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds. J Pharm Sci 2007;96(4):876-92
83. Zidan AS, Sammour OA, Hammad MA, et al. Quality by design: understanding the product variability of a self-nanoemulsified drug delivery system of cyclosporine A. J Pharm Sci 2007;96(9):2409-23.
84. Shah RB, Zidan AS, Funck T, et al. Quality by design: characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology. Int J Pharm 2007;341(1-2):189-94
85. Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 1997;25(1):103-28
86. Fatouros DG, Nielsen FS, Karpf DM, et al. Clinical studies with oral lipid based formulations of poorly soluble compounds. Ther Clin Risk Manag 2007;3(4):591-604